These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15271006)

  • 1. Comments on ethical issues with implantable defibrillators by F. James Brennan.
    Rahmoeller G
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):899. PubMed ID: 15271006
    [No Abstract]   [Full Text] [Related]  

  • 2. Ethical issues with implantable defibrillators.
    Brennan FJ
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):897-8. PubMed ID: 15271005
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethical issues with implantable defibrillators.
    Veenhuyzen GD; Simpson CS
    Pacing Clin Electrophysiol; 2005 Feb; 28(2):173-4; author reply 174. PubMed ID: 15679652
    [No Abstract]   [Full Text] [Related]  

  • 4. Comments on ethical issues with implantable defibrillators by F. James Brennan.
    Moss AJ
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):900. PubMed ID: 15271007
    [No Abstract]   [Full Text] [Related]  

  • 5. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking.
    Goldberger JJ; Passman R
    J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic implantable cardioverter-defibrillators after myocardial infarction--not for everyone.
    Gillis AM
    N Engl J Med; 2004 Dec; 351(24):2540-2. PubMed ID: 15590957
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indications for implantable cardioverter-defibrillator].
    Tebbenjohanns J; Niehaus M; Korte T
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2120-4. PubMed ID: 12397558
    [No Abstract]   [Full Text] [Related]  

  • 9. The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): rationale, design and specific aims.
    Grönefeld G; Connolly SJ; Hohnloser SH;
    Card Electrophysiol Rev; 2003 Dec; 7(4):447-51. PubMed ID: 15071273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable defibrillators and sudden cardiac death.
    Josephson M; Wellens HJ
    Circulation; 2004 Jun; 109(22):2685-91. PubMed ID: 15184292
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of sudden cardiac death in myocardial infarction survivors: insights from the randomized trials of implantable cardioverter-defibrillators.
    Bunch TJ; Hohnloser SH; Gersh BJ
    Circulation; 2007 May; 115(18):2451-7. PubMed ID: 17485594
    [No Abstract]   [Full Text] [Related]  

  • 12. [Usefulness of the implantable cardiodefibrillator (ICD) in the prevention of sudden death. Results of evidence based medicine].
    González CM
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-44-S2-46. PubMed ID: 17972377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trials update: sudden cardiac death prevention by implantable device therapy.
    Finch NJ; Leman RB
    Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate Risk-Stratification Improves Survival (IRIS): study protocol.
    Steinbeck G; Andresen D; Senges J; Hoffmann E; Seidl K; Brachmann J;
    Europace; 2004 Sep; 6(5):392-9. PubMed ID: 15294263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting patients for an implantable cardioverter-defibrillator: can the genie be put back into the bottle?
    Mittal S
    J Am Coll Cardiol; 2008 Jan; 51(3):297-9. PubMed ID: 18206739
    [No Abstract]   [Full Text] [Related]  

  • 16. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
    Proclemer A; Ghidina M
    J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
    [No Abstract]   [Full Text] [Related]  

  • 19. Revascularization versus implantable cardioverter-defibrillators to prevent sudden death in patients with severe left ventricular dysfunction.
    Weintraub WS
    Circulation; 2001 Sep; 104(13):1457-8. PubMed ID: 11571235
    [No Abstract]   [Full Text] [Related]  

  • 20. The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death.
    Sweeney MO
    Circulation; 2010 Dec; 122(25):2638-41. PubMed ID: 21135359
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.